BRAIN Biotech AG (LON:0RFI)

BRAIN Biotech AG Ratios and Metrics

Market cap in millions GBP. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 6, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	42	42	39	80	85	189
Market Cap Growth	-27.32%	7.86%	-52.03%	-5.24%	-55.24%	47.93%
Enterprise Value	55	32	29	77	73	183
Last Close Price	1.97	1.96	1.63	3.90	3.88	8.46
PS Ratio	0.97	0.95	0.84	1.65	1.92	5.63
PB Ratio	26.45	25.89	3.34	4.03	2.81	5.28
P/TBV Ratio	-	-	-	14.13	7.48	8.74
EV/Sales Ratio	1.26	0.74	0.62	1.58	1.65	5.44
Debt / Equity Ratio	11.27	11.27	1.89	0.45	0.31	0.27
Asset Turnover	0.65	0.65	0.70	0.76	0.65	0.52
Inventory Turnover	2.41	2.41	2.60	2.66	2.72	2.49
Quick Ratio	0.86	0.86	1.41	0.87	0.93	2.78
Current Ratio	1.42	1.42	1.83	1.46	1.42	3.45
Return on Equity (ROE)	-150.49%	-150.49%	-60.16%	-28.34%	-16.67%	-13.77%
Return on Assets (ROA)	-6.25%	-6.25%	-7.06%	-4.67%	-5.12%	-6.16%
Return on Capital Employed (ROCE)	-15.90%	-15.90%	-14.10%	-10.40%	-11.30%	-11.10%
Earnings Yield	-24.13%	-24.65%	-24.02%	-8.94%	-6.84%	-2.25%
FCF Yield	-22.12%	-22.60%	-11.09%	-7.38%	-7.56%	-2.34%
Buyback Yield / Dilution	-	-	-	-	-9.55%	-6.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.